+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of HBeAg negative chronic hepatitis B with new drugs

Treatment of HBeAg negative chronic hepatitis B with new drugs

Journal of Hepatology 39(Supplement 1): S172-S176

(PDF emailed within 1 workday: $29.90)

Accession: 035980441

Download citation: RISBibTeXText

Related references

Treatment of HBeAg negative chronic hepatitis B with new drugs (adefovir and others). Journal of Hepatology 39 Suppl 1: S172-S176, 2004

Long-term follow up of peginterferon-α-2a treatment of hepatitis B e-antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studies. Hepatology Research 46(10): 992-1001, 2015

New perspectives in the treatment of HBeAg-positive and HBeAg-negative chronic hepatitis B. Hepatology 41(6): 1402-1406, 2005

Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom. Value in Health 18(6): 800-809, 2016

Are hepatitis B e antigen (HBeAg)-positive chronic hepatitis B and HBeAg-negative chronic hepatitis B distinct diseases?. Clinical Infectious Diseases 47(10): 1312-1314, 2008

Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients. Jundishapur Journal of Microbiology 8(3): E21444-E21444, 2015

Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B. Liver International 30(8): 1115-1122, 2010

Histological Spectrum of Chronic Hepatitis in HBeAg Positive and HBeAg Negative Hepatitis B Virus Infection. Mymensingh Medical Journal 24(4): 679-683, 2016

The curative effect of adefovir dipivoxil treating HBeAg negative chronic hepatitis B and treating HBeAg positive chronic hepatitis B combining interferon α-2b. Pakistan Journal of Pharmaceutical Sciences 28(4 Suppl): 1493-1497, 2015

December 2017. Knee 24(6): 1261-1261, 2017

Hepatitis B surface antigen seroconversion in HBeAg negative chronic hepatitis B patient during entecavir treatment. Turkish Journal of Gastroenterology 25 Suppl 1: 272-273, 2015

Treatment of HBeAg-negative chronic hepatitis B. Seminars in Liver Disease 23(1): 81-88, 2003

Are we ready to use the hepatitis B surface antigen level to guide peginterferon treatment in HBeAg-negative chronic hepatitis B?. Hepatology International 7(1): 13-15, 2013

An analysis of clinical features in HBeAg-negative and HBeAg-positive chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 15(6): 428-430, 2007

Reversion from HBeAg negative to HBeAg positive phenotype after interferon therapy for chronic hepatitis B. Hepatology 30(4 PART 2): 601A, 1999